Denna webbsida är endast avsedd för läkare och sjukvårdspersonal med förskrivningsrätt.


9 – 10 November, 2023
Clarion Hotel & Congress Copenhagen Airport, Denmark

Janssen invites you to SCANPROST Meeting

Recent years have seen an accelerating pace in the development and adoption of new techniques in diagnosis and strategies in treatment of prostate cancer which has led to earlier treatment, improved outcomes and longer life for many patients. It is therefore our great pleasure to invite you to this years SCANPROST meetings to discuss and assess some of these recent developments.

On behalf of the SCANPROST Scientific Steering Committee

Gedske Daugaard, MD, PhD, Clinical Professor Department of Oncology, Rigshospitalet

Michael Borre, Professor, Department Clinical Medicine – Department of Urology, Aarhus University

Anders Bjartell, Professor, Urological cancer, Malmö and Division of Translational Cancer Research, Lund Universitya

Peter Busch Østergren Associate Professor, Department of Urology, Herlev and Gentofte Hospital










This meeting is towards healthcare professionals within uro-oncology with copy to principal/operations manager and relevant Medicines Committee.

This meeting is free of charge for its participants as Janssen finances this meeting. According to the agreement between LIF and SKR, pharmaceutical companies may not cover the cost of either travel or accommodation. For this reason, each participant is responsible for booking and paying its own travel and accommodation. Remember: the participant is responsible for the employer’s approval to participate in the meeting.

Janssen-Cilag AB cares about your privacy and wants you to know how we collect, use and share information. Your information will be used in accordance with our Privacy Policy and may be transferred to countries outside of your home country, including the United States, which may have different data protection rules than your country. Read our privacy policy on our website

Distribution of this invitation to hospital staff require prior approval from the hospital management.

Janssen-Cilag A/S cares about your privacy and wants you to be familiar with how we collect, use, and disclose information. To manage our professional relationship with you, we will use your information in accordance with our Privacy Policy

The event is/will be reported to ENLI (the Danish Ethical Board of the Medical Industry) before the event is held. The organizers believe that the arrangement is in accordance with the rules in this area, although that the event is not approved in advance by ENLI. EM-13097

For more information and registration